Health in 2 Point 00, Episode 151| MDLive (not?) IPOing, DTx Platform for Schizophrenia, & more

By | September 16, 2020

Health in 2 Point 00

We are forgetting about health tech, and celebrating Chicago-oo! Just kidding, today on Health in 2 Point 00, Jess asks me about Truepill getting a 75M Series C after just closing their B, Sana Benefits getting $ 20.8M, and Decent getting $ 10M, both of which are in the space of health benefits & insurance for small business have raised funding, MDLive closing a $ 50M round for their Virtual Primary Care (but weren’t they going public?), Owl Insights getting $ 15M from Ascension and Blue Ventures, and Boehringer Ingelheim & Click Therapeutics working on a $ 500M deal together on a DTx platform for Schizophrenia patients. –Matthew Holt

Subscribe to Health in 2 Point 00’s Channel

Follow @boltyboy & @jessdamassa on Twitter

Subscribe to our channel and tweet us your questions using the hashtag #healthin2point00!

Livongo’s Post Ad Banner 728*90

Spread the love

The Health Care Blog